nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—CYP3A4—bone cancer	0.491	1	CbGaD
Morphine—UGT2B7—Epirubicin—bone cancer	0.171	0.687	CbGbCtD
Morphine—ABCB1—Cisplatin—bone cancer	0.0232	0.0934	CbGbCtD
Morphine—ABCB1—Doxorubicin—bone cancer	0.0156	0.0626	CbGbCtD
Morphine—ABCB1—Methotrexate—bone cancer	0.0151	0.0606	CbGbCtD
Morphine—CYP2D6—Doxorubicin—bone cancer	0.0147	0.059	CbGbCtD
Morphine—CYP3A4—Doxorubicin—bone cancer	0.00933	0.0375	CbGbCtD
Morphine—Dihydrocodeine—CYP3A4—bone cancer	0.000916	0.166	CrCbGaD
Morphine—Oxymorphone—CYP3A4—bone cancer	0.000803	0.145	CrCbGaD
Morphine—Ethylmorphine—CYP3A4—bone cancer	0.000768	0.139	CrCbGaD
Morphine—Hydrocodone—CYP3A4—bone cancer	0.000702	0.127	CrCbGaD
Morphine—Codeine—CYP3A4—bone cancer	0.000611	0.111	CrCbGaD
Morphine—Naloxone—CYP3A4—bone cancer	0.000586	0.106	CrCbGaD
Morphine—Hydromorphone—CYP3A4—bone cancer	0.000582	0.105	CrCbGaD
Morphine—Galantamine—CYP3A4—bone cancer	0.000555	0.1	CrCbGaD
Morphine—UGT1A3—NRF2 pathway—TGFBR2—bone cancer	0.0003	0.00325	CbGpPWpGaD
Morphine—UGT1A3—NRF2 pathway—GSTP1—bone cancer	0.0003	0.00325	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—GRM1—bone cancer	0.0003	0.00324	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000299	0.00324	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—NT5C3A—bone cancer	0.000285	0.00309	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—NT5C3A—bone cancer	0.000285	0.00309	CbGpPWpGaD
Morphine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000277	0.003	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—GRM1—bone cancer	0.000272	0.00295	CbGpPWpGaD
Morphine—UGT1A3—Biological oxidations—GSTP1—bone cancer	0.000263	0.00285	CbGpPWpGaD
Morphine—UGT2B7—Biological oxidations—CYP3A4—bone cancer	0.000261	0.00283	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—GRM4—bone cancer	0.000261	0.00283	CbGpPWpGaD
Morphine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00026	0.00281	CbGpPWpGaD
Morphine—UGT1A3—Metapathway biotransformation—GSTP1—bone cancer	0.000259	0.00281	CbGpPWpGaD
Morphine—UGT2B7—Metapathway biotransformation—CYP3A4—bone cancer	0.000258	0.00279	CbGpPWpGaD
Morphine—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000256	0.00278	CbGpPWpGaD
Morphine—UGT2B7—NRF2 pathway—GSTP1—bone cancer	0.000255	0.00276	CbGpPWpGaD
Morphine—UGT2B7—NRF2 pathway—TGFBR2—bone cancer	0.000255	0.00276	CbGpPWpGaD
Morphine—Eosinophilia—Doxorubicin—bone cancer	0.000247	0.00152	CcSEcCtD
Morphine—Sweating—Methotrexate—bone cancer	0.000246	0.00151	CcSEcCtD
Morphine—Feeling abnormal—Cisplatin—bone cancer	0.000246	0.00151	CcSEcCtD
Morphine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000244	0.00264	CbGpPWpGaD
Morphine—Weight decreased—Epirubicin—bone cancer	0.000244	0.0015	CcSEcCtD
Morphine—Hyperglycaemia—Epirubicin—bone cancer	0.000243	0.00149	CcSEcCtD
Morphine—Hepatobiliary disease—Methotrexate—bone cancer	0.000243	0.00149	CcSEcCtD
Morphine—Drowsiness—Epirubicin—bone cancer	0.00024	0.00148	CcSEcCtD
Morphine—Renal failure—Epirubicin—bone cancer	0.000236	0.00145	CcSEcCtD
Morphine—Body temperature increased—Cisplatin—bone cancer	0.000236	0.00145	CcSEcCtD
Morphine—Stomatitis—Epirubicin—bone cancer	0.000234	0.00144	CcSEcCtD
Morphine—Conjunctivitis—Epirubicin—bone cancer	0.000233	0.00144	CcSEcCtD
Morphine—Urinary tract infection—Epirubicin—bone cancer	0.000233	0.00144	CcSEcCtD
Morphine—Dysuria—Doxorubicin—bone cancer	0.000233	0.00143	CcSEcCtD
Morphine—OPRL1—Circadian rythm related genes—JUN—bone cancer	0.000232	0.00251	CbGpPWpGaD
Morphine—Hepatitis—Methotrexate—bone cancer	0.00023	0.00142	CcSEcCtD
Morphine—Sweating—Epirubicin—bone cancer	0.00023	0.00142	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—GRM4—bone cancer	0.000229	0.00248	CbGpPWpGaD
Morphine—Urinary tract disorder—Methotrexate—bone cancer	0.000227	0.0014	CcSEcCtD
Morphine—Hepatobiliary disease—Epirubicin—bone cancer	0.000227	0.0014	CcSEcCtD
Morphine—OPRD1—GPCR ligand binding—GRM1—bone cancer	0.000226	0.00245	CbGpPWpGaD
Morphine—Urethral disorder—Methotrexate—bone cancer	0.000226	0.00139	CcSEcCtD
Morphine—Weight decreased—Doxorubicin—bone cancer	0.000225	0.00139	CcSEcCtD
Morphine—Hyperglycaemia—Doxorubicin—bone cancer	0.000225	0.00138	CcSEcCtD
Morphine—UGT2B7—Biological oxidations—GSTP1—bone cancer	0.000224	0.00242	CbGpPWpGaD
Morphine—Drowsiness—Doxorubicin—bone cancer	0.000222	0.00137	CcSEcCtD
Morphine—Visual impairment—Methotrexate—bone cancer	0.000222	0.00137	CcSEcCtD
Morphine—UGT2B7—Metapathway biotransformation—GSTP1—bone cancer	0.000221	0.00239	CbGpPWpGaD
Morphine—Hypersensitivity—Cisplatin—bone cancer	0.00022	0.00135	CcSEcCtD
Morphine—Bradycardia—Epirubicin—bone cancer	0.000219	0.00135	CcSEcCtD
Morphine—Renal failure—Doxorubicin—bone cancer	0.000218	0.00134	CcSEcCtD
Morphine—Stomatitis—Doxorubicin—bone cancer	0.000216	0.00133	CcSEcCtD
Morphine—Rhinitis—Epirubicin—bone cancer	0.000216	0.00133	CcSEcCtD
Morphine—Conjunctivitis—Doxorubicin—bone cancer	0.000216	0.00133	CcSEcCtD
Morphine—Urinary tract infection—Doxorubicin—bone cancer	0.000216	0.00133	CcSEcCtD
Morphine—Hepatitis—Epirubicin—bone cancer	0.000215	0.00133	CcSEcCtD
Morphine—Eye disorder—Methotrexate—bone cancer	0.000215	0.00132	CcSEcCtD
Morphine—Hypoaesthesia—Epirubicin—bone cancer	0.000214	0.00132	CcSEcCtD
Morphine—Asthenia—Cisplatin—bone cancer	0.000214	0.00132	CcSEcCtD
Morphine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000213	0.00231	CbGpPWpGaD
Morphine—Sweating—Doxorubicin—bone cancer	0.000213	0.00131	CcSEcCtD
Morphine—Urinary tract disorder—Epirubicin—bone cancer	0.000213	0.00131	CcSEcCtD
Morphine—UGT1A1—Biological oxidations—CYP3A4—bone cancer	0.000212	0.0023	CbGpPWpGaD
Morphine—Oedema peripheral—Epirubicin—bone cancer	0.000212	0.00131	CcSEcCtD
Morphine—Connective tissue disorder—Epirubicin—bone cancer	0.000212	0.0013	CcSEcCtD
Morphine—Urethral disorder—Epirubicin—bone cancer	0.000211	0.0013	CcSEcCtD
Morphine—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000211	0.00228	CbGpPWpGaD
Morphine—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00021	0.00228	CbGpPWpGaD
Morphine—Hepatobiliary disease—Doxorubicin—bone cancer	0.00021	0.00129	CcSEcCtD
Morphine—UGT1A1—Metapathway biotransformation—CYP3A4—bone cancer	0.00021	0.00227	CbGpPWpGaD
Morphine—Angiopathy—Methotrexate—bone cancer	0.000209	0.00129	CcSEcCtD
Morphine—Visual impairment—Epirubicin—bone cancer	0.000208	0.00128	CcSEcCtD
Morphine—Mediastinal disorder—Methotrexate—bone cancer	0.000208	0.00128	CcSEcCtD
Morphine—UGT1A1—NRF2 pathway—GSTP1—bone cancer	0.000207	0.00224	CbGpPWpGaD
Morphine—UGT1A1—NRF2 pathway—TGFBR2—bone cancer	0.000207	0.00224	CbGpPWpGaD
Morphine—Chills—Methotrexate—bone cancer	0.000207	0.00127	CcSEcCtD
Morphine—Diarrhoea—Cisplatin—bone cancer	0.000204	0.00126	CcSEcCtD
Morphine—Bradycardia—Doxorubicin—bone cancer	0.000203	0.00125	CcSEcCtD
Morphine—Mental disorder—Methotrexate—bone cancer	0.000202	0.00124	CcSEcCtD
Morphine—Eye disorder—Epirubicin—bone cancer	0.000201	0.00124	CcSEcCtD
Morphine—Erythema—Methotrexate—bone cancer	0.0002	0.00123	CcSEcCtD
Morphine—Malnutrition—Methotrexate—bone cancer	0.0002	0.00123	CcSEcCtD
Morphine—Flushing—Epirubicin—bone cancer	0.0002	0.00123	CcSEcCtD
Morphine—Rhinitis—Doxorubicin—bone cancer	0.0002	0.00123	CcSEcCtD
Morphine—Hepatitis—Doxorubicin—bone cancer	0.000199	0.00123	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—GRM1—bone cancer	0.000198	0.00215	CbGpPWpGaD
Morphine—Hypoaesthesia—Doxorubicin—bone cancer	0.000198	0.00122	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—bone cancer	0.000197	0.00121	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—bone cancer	0.000196	0.00121	CcSEcCtD
Morphine—Dysgeusia—Methotrexate—bone cancer	0.000196	0.00121	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—bone cancer	0.000196	0.00121	CcSEcCtD
Morphine—Angiopathy—Epirubicin—bone cancer	0.000195	0.0012	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—bone cancer	0.000195	0.0012	CcSEcCtD
Morphine—Mediastinal disorder—Epirubicin—bone cancer	0.000194	0.0012	CcSEcCtD
Morphine—Back pain—Methotrexate—bone cancer	0.000194	0.00119	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—GRM4—bone cancer	0.000193	0.00209	CbGpPWpGaD
Morphine—Chills—Epirubicin—bone cancer	0.000193	0.00119	CcSEcCtD
Morphine—OPRL1—GPCR downstream signaling—GNA11—bone cancer	0.000193	0.00209	CbGpPWpGaD
Morphine—Visual impairment—Doxorubicin—bone cancer	0.000192	0.00118	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—SMO—bone cancer	0.000192	0.00208	CbGpPWpGaD
Morphine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000192	0.00207	CbGpPWpGaD
Morphine—Vomiting—Cisplatin—bone cancer	0.00019	0.00117	CcSEcCtD
Morphine—Vision blurred—Methotrexate—bone cancer	0.000189	0.00116	CcSEcCtD
Morphine—Mental disorder—Epirubicin—bone cancer	0.000189	0.00116	CcSEcCtD
Morphine—Rash—Cisplatin—bone cancer	0.000188	0.00116	CcSEcCtD
Morphine—Dermatitis—Cisplatin—bone cancer	0.000188	0.00116	CcSEcCtD
Morphine—Malnutrition—Epirubicin—bone cancer	0.000188	0.00115	CcSEcCtD
Morphine—Erythema—Epirubicin—bone cancer	0.000188	0.00115	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—bone cancer	0.000186	0.00115	CcSEcCtD
Morphine—Ill-defined disorder—Methotrexate—bone cancer	0.000186	0.00114	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—RGS1—bone cancer	0.000185	0.00201	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—GRM4—bone cancer	0.000185	0.00201	CbGpPWpGaD
Morphine—Anaemia—Methotrexate—bone cancer	0.000185	0.00114	CcSEcCtD
Morphine—Flushing—Doxorubicin—bone cancer	0.000185	0.00114	CcSEcCtD
Morphine—Flatulence—Epirubicin—bone cancer	0.000185	0.00114	CcSEcCtD
Morphine—UGT1A3—Metabolism—NDUFA12—bone cancer	0.000184	0.002	CbGpPWpGaD
Morphine—Tension—Epirubicin—bone cancer	0.000184	0.00113	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—bone cancer	0.000184	0.00113	CcSEcCtD
Morphine—Nervousness—Epirubicin—bone cancer	0.000182	0.00112	CcSEcCtD
Morphine—UGT1A1—Biological oxidations—GSTP1—bone cancer	0.000182	0.00197	CbGpPWpGaD
Morphine—Back pain—Epirubicin—bone cancer	0.000181	0.00112	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—bone cancer	0.000181	0.00111	CcSEcCtD
Morphine—Malaise—Methotrexate—bone cancer	0.000181	0.00111	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—bone cancer	0.00018	0.00111	CcSEcCtD
Morphine—Vertigo—Methotrexate—bone cancer	0.00018	0.00111	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—bone cancer	0.00018	0.00111	CcSEcCtD
Morphine—Leukopenia—Methotrexate—bone cancer	0.000179	0.0011	CcSEcCtD
Morphine—UGT1A1—Metapathway biotransformation—GSTP1—bone cancer	0.000179	0.00194	CbGpPWpGaD
Morphine—Chills—Doxorubicin—bone cancer	0.000179	0.0011	CcSEcCtD
Morphine—Nausea—Cisplatin—bone cancer	0.000177	0.00109	CcSEcCtD
Morphine—Vision blurred—Epirubicin—bone cancer	0.000177	0.00109	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—GNA11—bone cancer	0.000175	0.0019	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—IL3—bone cancer	0.000175	0.0019	CbGpPWpGaD
Morphine—Cough—Methotrexate—bone cancer	0.000175	0.00108	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—bone cancer	0.000175	0.00108	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—bone cancer	0.000174	0.00107	CcSEcCtD
Morphine—Convulsion—Methotrexate—bone cancer	0.000174	0.00107	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—bone cancer	0.000174	0.00107	CcSEcCtD
Morphine—Erythema—Doxorubicin—bone cancer	0.000174	0.00107	CcSEcCtD
Morphine—Anaemia—Epirubicin—bone cancer	0.000173	0.00107	CcSEcCtD
Morphine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000173	0.00187	CbGpPWpGaD
Morphine—Agitation—Epirubicin—bone cancer	0.000172	0.00106	CcSEcCtD
Morphine—Flatulence—Doxorubicin—bone cancer	0.000171	0.00105	CcSEcCtD
Morphine—Arthralgia—Methotrexate—bone cancer	0.000171	0.00105	CcSEcCtD
Morphine—Chest pain—Methotrexate—bone cancer	0.000171	0.00105	CcSEcCtD
Morphine—Tension—Doxorubicin—bone cancer	0.00017	0.00105	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—bone cancer	0.00017	0.00105	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000169	0.00104	CcSEcCtD
Morphine—Malaise—Epirubicin—bone cancer	0.000169	0.00104	CcSEcCtD
Morphine—Discomfort—Methotrexate—bone cancer	0.000169	0.00104	CcSEcCtD
Morphine—Nervousness—Doxorubicin—bone cancer	0.000169	0.00104	CcSEcCtD
Morphine—Vertigo—Epirubicin—bone cancer	0.000169	0.00104	CcSEcCtD
Morphine—Syncope—Epirubicin—bone cancer	0.000168	0.00104	CcSEcCtD
Morphine—Leukopenia—Epirubicin—bone cancer	0.000168	0.00103	CcSEcCtD
Morphine—Back pain—Doxorubicin—bone cancer	0.000168	0.00103	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—GRM1—bone cancer	0.000168	0.00182	CbGpPWpGaD
Morphine—Muscle spasms—Doxorubicin—bone cancer	0.000167	0.00103	CcSEcCtD
Morphine—Palpitations—Epirubicin—bone cancer	0.000166	0.00102	CcSEcCtD
Morphine—Confusional state—Methotrexate—bone cancer	0.000165	0.00102	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—bone cancer	0.000165	0.00101	CcSEcCtD
Morphine—Cough—Epirubicin—bone cancer	0.000164	0.00101	CcSEcCtD
Morphine—Anaphylactic shock—Methotrexate—bone cancer	0.000164	0.00101	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—bone cancer	0.000164	0.00101	CcSEcCtD
Morphine—Convulsion—Epirubicin—bone cancer	0.000163	0.001	CcSEcCtD
Morphine—Infection—Methotrexate—bone cancer	0.000163	0.001	CcSEcCtD
Morphine—Hypertension—Epirubicin—bone cancer	0.000162	0.000997	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—bone cancer	0.000161	0.000991	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—GRM1—bone cancer	0.000161	0.00174	CbGpPWpGaD
Morphine—Nervous system disorder—Methotrexate—bone cancer	0.00016	0.000987	CcSEcCtD
Morphine—Anaemia—Doxorubicin—bone cancer	0.00016	0.000987	CcSEcCtD
Morphine—Thrombocytopenia—Methotrexate—bone cancer	0.00016	0.000986	CcSEcCtD
Morphine—Arthralgia—Epirubicin—bone cancer	0.00016	0.000983	CcSEcCtD
Morphine—Chest pain—Epirubicin—bone cancer	0.00016	0.000983	CcSEcCtD
Morphine—Agitation—Doxorubicin—bone cancer	0.000159	0.000982	CcSEcCtD
Morphine—OPRD1—GPCR ligand binding—SMO—bone cancer	0.000159	0.00173	CbGpPWpGaD
Morphine—Anxiety—Epirubicin—bone cancer	0.000159	0.00098	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—IL3—bone cancer	0.000159	0.00172	CbGpPWpGaD
Morphine—Skin disorder—Methotrexate—bone cancer	0.000159	0.000978	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000159	0.000976	CcSEcCtD
Morphine—Hyperhidrosis—Methotrexate—bone cancer	0.000158	0.000973	CcSEcCtD
Morphine—Discomfort—Epirubicin—bone cancer	0.000158	0.000971	CcSEcCtD
Morphine—UGT2B7—Metabolism—NDUFA12—bone cancer	0.000157	0.0017	CbGpPWpGaD
Morphine—Malaise—Doxorubicin—bone cancer	0.000157	0.000963	CcSEcCtD
Morphine—Dry mouth—Epirubicin—bone cancer	0.000156	0.000961	CcSEcCtD
Morphine—Vertigo—Doxorubicin—bone cancer	0.000156	0.00096	CcSEcCtD
Morphine—Anorexia—Methotrexate—bone cancer	0.000156	0.00096	CcSEcCtD
Morphine—Syncope—Doxorubicin—bone cancer	0.000156	0.000958	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—bone cancer	0.000155	0.000956	CcSEcCtD
Morphine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000155	0.00168	CbGpPWpGaD
Morphine—Confusional state—Epirubicin—bone cancer	0.000154	0.00095	CcSEcCtD
Morphine—Palpitations—Doxorubicin—bone cancer	0.000153	0.000944	CcSEcCtD
Morphine—Oedema—Epirubicin—bone cancer	0.000153	0.000942	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—bone cancer	0.000153	0.000942	CcSEcCtD
Morphine—OPRL1—Circadian rythm related genes—TP53—bone cancer	0.000153	0.00166	CbGpPWpGaD
Morphine—Hypotension—Methotrexate—bone cancer	0.000153	0.000941	CcSEcCtD
Morphine—UGT1A3—Metabolism—NT5C3A—bone cancer	0.000153	0.00165	CbGpPWpGaD
Morphine—Loss of consciousness—Doxorubicin—bone cancer	0.000153	0.000939	CcSEcCtD
Morphine—Infection—Epirubicin—bone cancer	0.000152	0.000936	CcSEcCtD
Morphine—Cough—Doxorubicin—bone cancer	0.000151	0.000932	CcSEcCtD
Morphine—Shock—Epirubicin—bone cancer	0.000151	0.000927	CcSEcCtD
Morphine—Convulsion—Doxorubicin—bone cancer	0.00015	0.000926	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—bone cancer	0.00015	0.000924	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—bone cancer	0.00015	0.000923	CcSEcCtD
Morphine—Hypertension—Doxorubicin—bone cancer	0.00015	0.000922	CcSEcCtD
Morphine—Tachycardia—Epirubicin—bone cancer	0.000149	0.00092	CcSEcCtD
Morphine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000149	0.000917	CcSEcCtD
Morphine—Skin disorder—Epirubicin—bone cancer	0.000149	0.000915	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—bone cancer	0.000148	0.000911	CcSEcCtD
Morphine—Insomnia—Methotrexate—bone cancer	0.000148	0.000911	CcSEcCtD
Morphine—Chest pain—Doxorubicin—bone cancer	0.000148	0.000909	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—bone cancer	0.000148	0.000909	CcSEcCtD
Morphine—OPRD1—GPCR downstream signaling—RGS1—bone cancer	0.000148	0.0016	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—GRM4—bone cancer	0.000148	0.0016	CbGpPWpGaD
Morphine—Anxiety—Doxorubicin—bone cancer	0.000147	0.000906	CcSEcCtD
Morphine—Paraesthesia—Methotrexate—bone cancer	0.000147	0.000904	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000147	0.000903	CcSEcCtD
Morphine—Discomfort—Doxorubicin—bone cancer	0.000146	0.000899	CcSEcCtD
Morphine—Anorexia—Epirubicin—bone cancer	0.000146	0.000898	CcSEcCtD
Morphine—Dyspnoea—Methotrexate—bone cancer	0.000146	0.000898	CcSEcCtD
Morphine—Somnolence—Methotrexate—bone cancer	0.000145	0.000895	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—bone cancer	0.000145	0.000889	CcSEcCtD
Morphine—Dyspepsia—Methotrexate—bone cancer	0.000144	0.000886	CcSEcCtD
Morphine—Hypotension—Epirubicin—bone cancer	0.000143	0.00088	CcSEcCtD
Morphine—UGT1A8—Metabolism—ENO2—bone cancer	0.000143	0.00155	CbGpPWpGaD
Morphine—Confusional state—Doxorubicin—bone cancer	0.000143	0.000879	CcSEcCtD
Morphine—Decreased appetite—Methotrexate—bone cancer	0.000142	0.000875	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—bone cancer	0.000142	0.000872	CcSEcCtD
Morphine—Oedema—Doxorubicin—bone cancer	0.000142	0.000872	CcSEcCtD
Morphine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000141	0.000869	CcSEcCtD
Morphine—Fatigue—Methotrexate—bone cancer	0.000141	0.000868	CcSEcCtD
Morphine—Infection—Doxorubicin—bone cancer	0.000141	0.000866	CcSEcCtD
Morphine—Pain—Methotrexate—bone cancer	0.00014	0.000861	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—SMO—bone cancer	0.00014	0.00151	CbGpPWpGaD
Morphine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000139	0.000858	CcSEcCtD
Morphine—Shock—Doxorubicin—bone cancer	0.000139	0.000858	CcSEcCtD
Morphine—OPRM1—TCR Signaling Pathway—JUN—bone cancer	0.000139	0.00151	CbGpPWpGaD
Morphine—Nervous system disorder—Doxorubicin—bone cancer	0.000139	0.000855	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—bone cancer	0.000139	0.000854	CcSEcCtD
Morphine—Insomnia—Epirubicin—bone cancer	0.000138	0.000852	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—bone cancer	0.000138	0.000851	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—bone cancer	0.000138	0.000847	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—bone cancer	0.000137	0.000846	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—bone cancer	0.000137	0.000843	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—bone cancer	0.000136	0.00084	CcSEcCtD
Morphine—Somnolence—Epirubicin—bone cancer	0.000136	0.000838	CcSEcCtD
Morphine—Anorexia—Doxorubicin—bone cancer	0.000135	0.000831	CcSEcCtD
Morphine—Feeling abnormal—Methotrexate—bone cancer	0.000135	0.00083	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—bone cancer	0.000135	0.000829	CcSEcCtD
Morphine—OPRD1—Signaling by GPCR—RGS1—bone cancer	0.000134	0.00145	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—GRM4—bone cancer	0.000134	0.00145	CbGpPWpGaD
Morphine—Gastrointestinal pain—Methotrexate—bone cancer	0.000134	0.000823	CcSEcCtD
Morphine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000133	0.00144	CbGpPWpGaD
Morphine—Decreased appetite—Epirubicin—bone cancer	0.000133	0.000819	CcSEcCtD
Morphine—UGT1A8—Metabolism—DHFR—bone cancer	0.000133	0.00143	CbGpPWpGaD
Morphine—Hypotension—Doxorubicin—bone cancer	0.000132	0.000815	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000132	0.000813	CcSEcCtD
Morphine—Fatigue—Epirubicin—bone cancer	0.000132	0.000812	CcSEcCtD
Morphine—Pain—Epirubicin—bone cancer	0.000131	0.000806	CcSEcCtD
Morphine—Constipation—Epirubicin—bone cancer	0.000131	0.000806	CcSEcCtD
Morphine—Urticaria—Methotrexate—bone cancer	0.00013	0.0008	CcSEcCtD
Morphine—UGT2B7—Metabolism—NT5C3A—bone cancer	0.00013	0.00141	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—RGS1—bone cancer	0.000129	0.0014	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—GRM4—bone cancer	0.000129	0.0014	CbGpPWpGaD
Morphine—Abdominal pain—Methotrexate—bone cancer	0.000129	0.000796	CcSEcCtD
Morphine—Body temperature increased—Methotrexate—bone cancer	0.000129	0.000796	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000129	0.000794	CcSEcCtD
Morphine—Insomnia—Doxorubicin—bone cancer	0.000128	0.000789	CcSEcCtD
Morphine—OPRD1—GPCR downstream signaling—GRM1—bone cancer	0.000128	0.00138	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NDUFA12—bone cancer	0.000127	0.00138	CbGpPWpGaD
Morphine—Paraesthesia—Doxorubicin—bone cancer	0.000127	0.000783	CcSEcCtD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000127	0.00138	CbGpPWpGaD
Morphine—Dyspnoea—Doxorubicin—bone cancer	0.000126	0.000777	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—bone cancer	0.000126	0.000776	CcSEcCtD
Morphine—Somnolence—Doxorubicin—bone cancer	0.000126	0.000775	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—bone cancer	0.000125	0.00077	CcSEcCtD
Morphine—UGT2B15—Metabolism—ENO2—bone cancer	0.000125	0.00135	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—ENO2—bone cancer	0.000125	0.00135	CbGpPWpGaD
Morphine—Dyspepsia—Doxorubicin—bone cancer	0.000125	0.000767	CcSEcCtD
Morphine—UGT1A8—Metabolism—GNA11—bone cancer	0.000124	0.00134	CbGpPWpGaD
Morphine—Decreased appetite—Doxorubicin—bone cancer	0.000123	0.000758	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000122	0.000753	CcSEcCtD
Morphine—Fatigue—Doxorubicin—bone cancer	0.000122	0.000752	CcSEcCtD
Morphine—Urticaria—Epirubicin—bone cancer	0.000122	0.000749	CcSEcCtD
Morphine—Pain—Doxorubicin—bone cancer	0.000121	0.000746	CcSEcCtD
Morphine—Constipation—Doxorubicin—bone cancer	0.000121	0.000746	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—bone cancer	0.000121	0.000745	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—bone cancer	0.000121	0.000745	CcSEcCtD
Morphine—Hypersensitivity—Methotrexate—bone cancer	0.000121	0.000742	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—SMO—bone cancer	0.000118	0.00128	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—GRM4—bone cancer	0.000117	0.00127	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—RGS1—bone cancer	0.000117	0.00127	CbGpPWpGaD
Morphine—Asthenia—Methotrexate—bone cancer	0.000117	0.000722	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—bone cancer	0.000117	0.000718	CcSEcCtD
Morphine—OPRD1—Signaling by GPCR—GRM1—bone cancer	0.000116	0.00126	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—DHFR—bone cancer	0.000116	0.00125	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—DHFR—bone cancer	0.000116	0.00125	CbGpPWpGaD
Morphine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000116	0.000713	CcSEcCtD
Morphine—Pruritus—Methotrexate—bone cancer	0.000116	0.000712	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—SMO—bone cancer	0.000113	0.00123	CbGpPWpGaD
Morphine—Hypersensitivity—Epirubicin—bone cancer	0.000113	0.000694	CcSEcCtD
Morphine—Urticaria—Doxorubicin—bone cancer	0.000113	0.000693	CcSEcCtD
Morphine—UGT1A8—Metabolism—CYP3A4—bone cancer	0.000112	0.00122	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—GRM1—bone cancer	0.000112	0.00121	CbGpPWpGaD
Morphine—Body temperature increased—Doxorubicin—bone cancer	0.000112	0.000689	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—bone cancer	0.000112	0.000689	CcSEcCtD
Morphine—Diarrhoea—Methotrexate—bone cancer	0.000112	0.000689	CcSEcCtD
Morphine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000112	0.00121	CbGpPWpGaD
Morphine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.00011	0.00119	CbGpPWpGaD
Morphine—Asthenia—Epirubicin—bone cancer	0.00011	0.000676	CcSEcCtD
Morphine—OPRM1—GPCR downstream signaling—RGS1—bone cancer	0.000109	0.00118	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—GRM4—bone cancer	0.000109	0.00118	CbGpPWpGaD
Morphine—Pruritus—Epirubicin—bone cancer	0.000108	0.000667	CcSEcCtD
Morphine—UGT2B4—Metabolism—GNA11—bone cancer	0.000108	0.00117	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—GNA11—bone cancer	0.000108	0.00117	CbGpPWpGaD
Morphine—Dizziness—Methotrexate—bone cancer	0.000108	0.000666	CcSEcCtD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000108	0.00117	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NT5C3A—bone cancer	0.000106	0.00114	CbGpPWpGaD
Morphine—Diarrhoea—Epirubicin—bone cancer	0.000105	0.000645	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—bone cancer	0.000104	0.000642	CcSEcCtD
Morphine—Vomiting—Methotrexate—bone cancer	0.000104	0.00064	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—GNA11—bone cancer	0.000104	0.00112	CbGpPWpGaD
Morphine—Rash—Methotrexate—bone cancer	0.000103	0.000635	CcSEcCtD
Morphine—Dermatitis—Methotrexate—bone cancer	0.000103	0.000634	CcSEcCtD
Morphine—Headache—Methotrexate—bone cancer	0.000102	0.000631	CcSEcCtD
Morphine—OPRK1—Signaling by GPCR—GRM1—bone cancer	0.000102	0.0011	CbGpPWpGaD
Morphine—Asthenia—Doxorubicin—bone cancer	0.000102	0.000626	CcSEcCtD
Morphine—Dizziness—Epirubicin—bone cancer	0.000101	0.000623	CcSEcCtD
Morphine—Pruritus—Doxorubicin—bone cancer	0.0001	0.000617	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—RGS1—bone cancer	9.93e-05	0.00107	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—GRM4—bone cancer	9.93e-05	0.00107	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.84e-05	0.00107	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—CYP3A4—bone cancer	9.82e-05	0.00106	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—CYP3A4—bone cancer	9.82e-05	0.00106	CbGpPWpGaD
Morphine—Vomiting—Epirubicin—bone cancer	9.73e-05	0.000599	CcSEcCtD
Morphine—Nausea—Methotrexate—bone cancer	9.72e-05	0.000598	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—bone cancer	9.69e-05	0.000597	CcSEcCtD
Morphine—Rash—Epirubicin—bone cancer	9.65e-05	0.000594	CcSEcCtD
Morphine—Dermatitis—Epirubicin—bone cancer	9.64e-05	0.000594	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—ATF1—bone cancer	9.63e-05	0.00104	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—GSTP1—bone cancer	9.6e-05	0.00104	CbGpPWpGaD
Morphine—Headache—Epirubicin—bone cancer	9.59e-05	0.00059	CcSEcCtD
Morphine—CYP2C8—Biological oxidations—GSTP1—bone cancer	9.57e-05	0.00104	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—GRM1—bone cancer	9.48e-05	0.00103	CbGpPWpGaD
Morphine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	9.44e-05	0.00102	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL3—bone cancer	9.39e-05	0.00102	CbGpPWpGaD
Morphine—Dizziness—Doxorubicin—bone cancer	9.37e-05	0.000577	CcSEcCtD
Morphine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	9.18e-05	0.000994	CbGpPWpGaD
Morphine—Nausea—Epirubicin—bone cancer	9.09e-05	0.00056	CcSEcCtD
Morphine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	9.06e-05	0.000981	CbGpPWpGaD
Morphine—Vomiting—Doxorubicin—bone cancer	9.01e-05	0.000554	CcSEcCtD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	8.96e-05	0.00097	CbGpPWpGaD
Morphine—Rash—Doxorubicin—bone cancer	8.93e-05	0.00055	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—bone cancer	8.92e-05	0.000549	CcSEcCtD
Morphine—Headache—Doxorubicin—bone cancer	8.87e-05	0.000546	CcSEcCtD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.84e-05	0.000957	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—GRM1—bone cancer	8.61e-05	0.000932	CbGpPWpGaD
Morphine—Nausea—Doxorubicin—bone cancer	8.41e-05	0.000518	CcSEcCtD
Morphine—UGT2B15—Metabolism—GSTP1—bone cancer	8.4e-05	0.000909	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—GSTP1—bone cancer	8.4e-05	0.000909	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.38e-05	0.000907	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—GNA11—bone cancer	8.24e-05	0.000892	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—SMO—bone cancer	8.18e-05	0.000886	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TGFBR2—bone cancer	8.03e-05	0.000869	CbGpPWpGaD
Morphine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.93e-05	0.000858	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GRM4—bone cancer	7.91e-05	0.000857	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RGS1—bone cancer	7.91e-05	0.000857	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—GSTP1—bone cancer	7.85e-05	0.00085	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	7.75e-05	0.000839	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IGF1R—bone cancer	7.56e-05	0.000818	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.49e-05	0.000811	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—GNA11—bone cancer	7.48e-05	0.00081	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—IL3—bone cancer	7.47e-05	0.000809	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.47e-05	0.000809	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—GNA11—bone cancer	7.23e-05	0.000782	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—SMO—bone cancer	7.18e-05	0.000777	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RGS1—bone cancer	6.94e-05	0.000751	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GRM4—bone cancer	6.94e-05	0.000751	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GRM1—bone cancer	6.86e-05	0.000743	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL3—bone cancer	6.79e-05	0.000735	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NDUFA12—bone cancer	6.71e-05	0.000726	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ENO2—bone cancer	6.69e-05	0.000724	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—GNA11—bone cancer	6.56e-05	0.000711	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL3—bone cancer	6.55e-05	0.000709	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.45e-05	0.000698	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—DHFR—bone cancer	6.21e-05	0.000672	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—GNA11—bone cancer	6.11e-05	0.000661	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—SMO—bone cancer	6.06e-05	0.000657	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GRM1—bone cancer	6.02e-05	0.000651	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL3—bone cancer	5.95e-05	0.000644	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RGS1—bone cancer	5.86e-05	0.000635	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GRM4—bone cancer	5.86e-05	0.000635	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NDUFA12—bone cancer	5.84e-05	0.000632	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GNA11—bone cancer	5.8e-05	0.000628	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ENO2—bone cancer	5.69e-05	0.000616	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.56e-05	0.000602	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NT5C3A—bone cancer	5.56e-05	0.000602	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—GNA11—bone cancer	5.55e-05	0.000601	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL3—bone cancer	5.54e-05	0.0006	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NDUFA12—bone cancer	5.5e-05	0.000596	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—KIT—bone cancer	5.48e-05	0.000593	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—DHFR—bone cancer	5.28e-05	0.000571	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CYP3A4—bone cancer	5.26e-05	0.000569	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—BRAF—bone cancer	5.15e-05	0.000558	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.14e-05	0.000556	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GRM1—bone cancer	5.08e-05	0.000551	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.06e-05	0.000548	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL3—bone cancer	5.03e-05	0.000544	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—EGFR—bone cancer	4.99e-05	0.000541	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PTGS2—bone cancer	4.98e-05	0.000539	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GNA11—bone cancer	4.93e-05	0.000534	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NT5C3A—bone cancer	4.84e-05	0.000524	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SMO—bone cancer	4.83e-05	0.000523	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ENO2—bone cancer	4.62e-05	0.0005	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NT5C3A—bone cancer	4.56e-05	0.000494	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GSTP1—bone cancer	4.5e-05	0.000487	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP3A4—bone cancer	4.47e-05	0.000484	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GNA11—bone cancer	4.42e-05	0.000479	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTGS2—bone cancer	4.35e-05	0.000471	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTGS2—bone cancer	4.35e-05	0.000471	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MDM2—bone cancer	4.32e-05	0.000467	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—DHFR—bone cancer	4.29e-05	0.000464	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SMO—bone cancer	4.24e-05	0.000459	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.12e-05	0.000446	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ATF1—bone cancer	4.11e-05	0.000445	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL3—bone cancer	4.01e-05	0.000434	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GNA11—bone cancer	4.01e-05	0.000434	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.97e-05	0.00043	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GNA11—bone cancer	3.88e-05	0.00042	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GSTP1—bone cancer	3.82e-05	0.000414	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—JUN—bone cancer	3.75e-05	0.000406	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MMP9—bone cancer	3.65e-05	0.000395	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP3A4—bone cancer	3.63e-05	0.000393	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ATF1—bone cancer	3.6e-05	0.00039	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NDUFA12—bone cancer	3.6e-05	0.00039	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SMO—bone cancer	3.58e-05	0.000388	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.58e-05	0.000388	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL3—bone cancer	3.51e-05	0.000381	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFBR2—bone cancer	3.43e-05	0.000371	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GNA11—bone cancer	3.28e-05	0.000355	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF1R—bone cancer	3.23e-05	0.000349	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTP1—bone cancer	3.11e-05	0.000336	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ATF1—bone cancer	3.05e-05	0.00033	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFBR2—bone cancer	3.01e-05	0.000325	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.98e-05	0.000323	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL3—bone cancer	2.97e-05	0.000322	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EGFR—bone cancer	2.95e-05	0.000319	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1R—bone cancer	2.83e-05	0.000306	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.81e-05	0.000305	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFBR2—bone cancer	2.54e-05	0.000275	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—bone cancer	2.48e-05	0.000268	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ENO2—bone cancer	2.43e-05	0.000263	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1R—bone cancer	2.39e-05	0.000259	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.36e-05	0.000256	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KIT—bone cancer	2.34e-05	0.000253	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—bone cancer	2.33e-05	0.000252	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—DHFR—bone cancer	2.26e-05	0.000244	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—BRAF—bone cancer	2.2e-05	0.000238	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—bone cancer	2.13e-05	0.000231	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ENO2—bone cancer	2.12e-05	0.00023	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GNA11—bone cancer	2.11e-05	0.000228	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KIT—bone cancer	2.05e-05	0.000222	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ENO2—bone cancer	2e-05	0.000216	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—bone cancer	1.98e-05	0.000214	CbGpPWpGaD
Morphine—ABCB1—Metabolism—DHFR—bone cancer	1.97e-05	0.000213	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—BRAF—bone cancer	1.93e-05	0.000209	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.91e-05	0.000207	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.9e-05	0.000206	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—bone cancer	1.87e-05	0.000202	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—DHFR—bone cancer	1.85e-05	0.000201	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MDM2—bone cancer	1.84e-05	0.000199	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GNA11—bone cancer	1.84e-05	0.000199	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KIT—bone cancer	1.73e-05	0.000188	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GNA11—bone cancer	1.73e-05	0.000188	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP3A4—bone cancer	1.67e-05	0.00018	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTP1—bone cancer	1.64e-05	0.000177	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BRAF—bone cancer	1.63e-05	0.000176	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MDM2—bone cancer	1.62e-05	0.000175	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—bone cancer	1.61e-05	0.000174	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—JUN—bone cancer	1.6e-05	0.000173	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—bone cancer	1.58e-05	0.000171	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.57e-05	0.00017	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—bone cancer	1.56e-05	0.000169	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTP1—bone cancer	1.43e-05	0.000154	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—JUN—bone cancer	1.4e-05	0.000152	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—bone cancer	1.37e-05	0.000148	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MDM2—bone cancer	1.37e-05	0.000148	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTP1—bone cancer	1.34e-05	0.000145	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ENO2—bone cancer	1.31e-05	0.000141	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—bone cancer	1.26e-05	0.000136	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—DHFR—bone cancer	1.21e-05	0.000131	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—JUN—bone cancer	1.19e-05	0.000128	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—bone cancer	1.15e-05	0.000125	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GNA11—bone cancer	1.13e-05	0.000123	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—bone cancer	1.1e-05	0.00012	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—bone cancer	1.06e-05	0.000114	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—bone cancer	9.33e-06	0.000101	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—bone cancer	9.27e-06	0.0001	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTP1—bone cancer	8.78e-06	9.51e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—bone cancer	8.48e-06	9.18e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—bone cancer	7.83e-06	8.48e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—bone cancer	7.38e-06	7.99e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—bone cancer	6.96e-06	7.53e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—bone cancer	4.55e-06	4.93e-05	CbGpPWpGaD
